Histogen Inc. (HSTOQ)
OTCMKTS · Delayed Price · Currency is USD
0.0112
0.00 (0.00%)
Nov 7, 2025, 4:00 PM EST
Histogen Market Cap
Histogen has a market cap or net worth of $48.06 thousand as of November 7, 2025. Its market cap has decreased by -96.64% in one year.
Market Cap
48.06K
Enterprise Value
n/a
Revenue
19.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since May 27, 2020, Histogen's market cap has decreased from 15.29M to 48.06K, a decrease of -99.69%. That is a compound annual growth rate of -65.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 48.06K | -55.00% |
| Dec 31, 2024 | 106.79K | -91.88% |
| Dec 29, 2023 | 1.31M | -62.93% |
| Dec 30, 2022 | 3.55M | -78.66% |
| Dec 31, 2021 | 16.62M | 45.86% |
| Dec 31, 2020 | 11.39M | -25.49% |
| May 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.15M |
| Elite Pharmaceuticals | 659.64M |
| Glass House Brands | 595.49M |
| Northwest Biotherapeutics | 373.25M |
| American Oncology Network | 326.52M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 308.64M |
| Silence Therapeutics | 294.74M |